Xillix Technologies
Richmond, BC
Company Overview
Xillix Technologies Corp. is a Canadian medical device company focused on the research, development and commercialization of fluorescence endoscopy for the improved detection and localization of cancer.
The Company's core technology, known internationally as Xillix Life(tm) (Light Induced Fluorescence Endoscopy), helps physicians diagnose early-stage lung and gastrointestinal (GI) cancers. The Company's first-generation product, Xillix LIFE-Lung(tm), achieved worldwide regulatory approvals including US Food & Drug Administration (FDA) Pre-Market Approval (PMA).
Onco-LIFE(tm), the Company's latest device, developed for lung and GI applications incorporates conventional white-light and fluorescence endoscopy in a single device that is compatible with a wide range of endoscopes. On June 30, 2005, Xillix received U. S. FDA approval for its Pre-Market (PMA) Supplement (P950042/S003) for Onco-LIFE, in the lung application. An international multi-center clinical trial demonstrated a 325% per-lesion improvement in the early detection of lung cancer (moderate-severe dysplasia and carcinoma in situ) and a 250% per-patient improvement, compared to white-light alone.
Onco-LIFE is approved for sale in the United States for the lung application and in Europe and Canada for both lung and GI applications.
Company Information
Physical Address
100-13775 Commerce Pky.
Richmond, BC V6V 2V4
CA
Mailing Address
100-13775 Commerce Pky.
Richmond, BC V6V 2V4
CA
Additional Details
Legal Name: Xillix Technologies Corp.
Number of Employees: 65
CA
Xillix is a leader in the development and commercialization of proprietary medical imaging technology which helps physicians to diagnose early-stage cancer.
Contacts
Brett Gannon
Title: Chief Operating Officer
Area of Responsibility: Manufacturing/Production/Operations
Phone: Show phone
Fax: Show fax
Email: Show email
Patrick Du Monceaux
Title: Vice President
Area of Responsibility: Domestic Sales & Marketing
Phone: Show phone
Fax: Show fax
Email: Show email
John Fengler
Title: Vice President
Area of Responsibility: Research/Development/Engineering
Phone: Show phone
Fax: Show fax
Email: Show email
Rob Ngungu
Title: Vice President
Area of Responsibility: Management Executive
Phone: Show phone
Fax: Show fax
Email: Show email
Cynthia Roney
Title: Chief Executive Officer
Area of Responsibility: Management Executive
Phone: Show phone
Fax: Show fax
Email: Show email
Products
- Autofluorescence
-
Diagnostic Equipment
Onco-LIFE(tm)
-
Fluorescence Imaging
Early detection of cancer through fluorescence imaging
-
Life-lung
Xillix's first generation medical device for the early detection of lung cancer. This product was approved by the FDA in the US in
- The product was sold world wide during the period 1994 to
mid 1999.
-
Life-lung System
Xillix's first generation medical device for the early detection of lung cancer. This product was approved by the FDA in the US in
- The product was sold world wide during the period 1994 to
mid 1999.
-
Onco-life Gi
A medical device, for the early detection of gastrointestinal cancers.
- Onco-life Lung
NAICS Categories
Additional Information
334512
6515-Medical and Surgical Instruments, Equipment, and Supplies, AN00-Medical, G009-Other Health Services
Austria, Bahrain, Bangladesh, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Germany, Greece, Hungary, India, Iran, Ireland, Republic of (EIRE), Israel, Italy, Jordan, Kuwait, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Pakistan, Poland, Portugal, Romania, Saudi Arabia, Serbia and Montenegro, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom, United States
Russian Federation